Latest filing published 03 Dec 2025 for MiNK Therapeutics, Inc., €12k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Ulf Wiinberg is a declared insider at 2 companies; the most frequent names are MiNK Therapeutics, Inc. and Agenus Inc. Between 16 June 2021 and 1 December 2025, the trades on record add up to 17 filings.
Purchases make up the whole of the open-market record (2 purchases, €22k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 14 share grants and 1 option exercise.
On 3 December 2025 came the latest disclosure, a share grant for €12k in MiNK Therapeutics, Inc. The most recent open-market purchase was published on 17 November 2023, 1,066 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations